(219 days)
Not Found
No
The document describes a mechanical hip prosthesis and does not mention any software, algorithms, or AI/ML capabilities.
Yes
The device is a prosthesis designed to replace a damaged hip femoral neck and head, which is a therapeutic intervention for conditions like degenerative joint disease, arthritis, and fractures.
No
Explanation: The device is a prosthetic hip implant designed to replace a damaged femoral neck and head, not to diagnose a condition. Its indications for use are for treatment, not diagnosis.
No
The device description clearly states it is a physical implant made from forged Co-Cr-Mo and PMMA, intended to replace the femoral neck and head. It is a hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The Generation 4® Polished Femoral Hip Prosthesis is a physical implant designed to replace damaged parts of the hip joint. It is surgically implanted into the patient's body.
- Intended Use: The intended use clearly describes the device as a prosthesis for treating various hip conditions and replacing damaged bone structures. This is a therapeutic and structural intervention, not a diagnostic test performed on a sample.
Therefore, this device falls under the category of a surgical implant or prosthesis, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The indications for use for the Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer include:
- Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
- Rheumatoid Arthritis.
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable using other techniques.
- Revision of previously failed total hip arthroplasty.
The Generation 4® Polished Femoral Hip Prosthesis with Proximal Coment Spacer is intended for cemented use only and may be used in partial and total hip arthroplasties.
Product codes (comma separated list FDA assigned to the subject device)
JDI, LZO, KWZ, MEH, LPH, KWY, JDG
Device Description
The Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer is designed to replace the patient's natural hip femoral neck and head damaged due to disease or accident. The femoral hip prosthesis is made from forged Co-Cr-Mo per ASTM F799, and the proximal cement spacers are made from polymethylmethacrylate (PMMA). The implants are designed for use with bone cement. General implant surfaces are highly polished. In addition to the proximal cement spacer, an optional distal cement centralizer (cleared in K942479) is available for optimum stem placement within the canal.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hip, femoral neck and head
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical laboratory testing was performed to determine substantial equivalence. The results indicated that the device was functional within its intended use.
No clinical testing was necessary for determination of substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
510(k) Summary K052639
Preparation Date:
Applicant/Sponsor:
Proprietary Name:
Classification Name:
April 12, 2006
Biomet Manufacturing Corp.
MAY 3 2006
Contact Person: Susan Alexander
Generation 4® Polished Femoral Hip System with Proximal Cement Spacer
Common Name: Prosthesis, Hip, Femoral Component, Cemented, Metal
The Generation 4® Polished Femoral Hip Prosthesis has the following classification: Class II, 21 CFR §888.3350.
The mating components (modular heads and acetabular shells/liners) for use with the Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer have the following classifications:
Hip joint metal/polymer constrained cemented or 1. uncemented prosthesis (21 CFR $888.3310), Product Code: KWZ
-
- Hip joint metal/polymer semi-constrained cemented prosthesis (21 CFRS 888.3350), Product Code: JDI
-
- Hip joint femoral (hemi-hip) metallic cemented or uncemented prosthesis (21 CFR$ 888.3360), Product Code: JDG
-
- Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis (21 CFR §888.3353), Product Code: MEH
- Hip joint metal/polymer/metal semi-constrained, porous-ട്. coated, uncemented prosthesis (21 C.F.R. §888.3358), Product Code: LPH
- Hip joint (hemi-hip) acetabular metal cemented ల్. prosthesis (21 CFR §888.3370), Product Code: LZY
- 7 . Hip joint femoral (hemi-hip) metal/polymer cemented or uncemented prosthesis (21 CFR58888.3390), Product Code: KWY
-
- Hip joint metal/ceramic/polymer semi-constrained cemented or nonporous uncemented prosthesis (21 CFR §888.3353), Product Code: LZO
| MAILING ADDRESS | SHIPPING ADDRESS |
|---|---|
| P.O. Box 587 | 56 E. Bell Drive |
| Warsaw, IN 46581 0587 | Warsaw, IN 46582 |
| OFFICE | 574.267.66.39 |
|---|---|
| FAX | 574.267.8157 |
| biomet@biomet.com |
1
510(k) Summary Generation 4 Polished Femoral Hip Prosthesis with Cement Spacer Page 2 of 3
Legally Marketed Devices to Which Substantial Equivalence Is Claimed:
-
Generation 48 Polished Femoral Hip Prosthesis - Biomet Manufacturing Corp. (K031734)
- A Rx-90™ Femoral Stems and Lateralized Stems - Biomet Manufacturing Corp. (K023085)
- A Rx-90™ Femoral Component - Biomet, Inc. (K942028)
The Generation 48 Polished Femoral Hip Prosthesis with Device Description: Proximal Cement Spacer is designed to replace the patient's natural hip femoral neck and head damaged due to disease or accident. The femoral hip prosthesis is made from forged Co-Cr-Mo per ASTM F799, and the proximal cement spacers are made from polymethylmethacrylate (PMMA). The implants are designed for use with bone cement. General implant surfaces are highly polished. In addition to the proximal cement spacer, an optional distal cement centralizer (cleared in K942479) is available for optimum stem placement within the canal.
The indications for use for the Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer include:
- Non-inflammatory degenerative joint disease 1 including osteoarthritis and avascular necrosis.
- Rheumatoid Arthritis. 2.
-
- Correction of functional deformity.
- Treatment of non-union, femoral neck র্বা fracture, and trochanteric fractures of the proximal femur with head involvement. unmanageable using other techniques.
- ક. Revision of previously failed total hip arthroplasty.
The Generation 48 Polished Femoral Hip Prosthesis with Proximal Cement Spacer is intended for cemented use only and may be used in partial and total hip arthroplasties.
The Generation 48 Polished Femoral Hip System is manufactured from the same materials, utilizing the same manufacturing practices, and conforming to the same standards as other femoral hip prostheses cleared for cemented use.
Indications
Summary of Technologies:
2
510(k) Summary Generation 4 Polished Femoral Hip Prosthesis with Cement Spacer Page 3 of 3
Non-Clinical Testing:
Clinical Testing:
Non-clinical laboratory testing was performed to determine substantial equivalence. The results indicated that the device was functional within its intended use.
No clinical testing was necessary for determination of substantial equivalence.
All trademarks are property of Biomet, Inc.
3
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the top half of the circle. Inside the circle is a stylized design featuring three abstract human profiles facing to the right, with flowing lines suggesting movement or connection.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 23 2009
Biomet Manufacturing Corp. % Ms. Susan Alexander Regulatory Specialist P. O. Box 587 Warsaw, Indiana 46581-0587
Re: K052639
Trade/Device Name: Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer Regulation Number: 21 CFR 888.3350 Regulation Name: Hip joint metal/polymer semi-constrained cemented prosthesis Regulatory Class: II Product Code: JDI, LZO, KWZ, MEH, LPH, KWY, JDG Dated: April 12, 2006 Received: April 13, 2006
Dear Ms. Alexander:
This letter corrects our substantially equivalent letter of May 3, 2006.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not
4
Page 2 - Ms. Susan Alexander
limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please contact the CDRH/Office of Surveillance and Biometrics/Division of Postmarket Surveillance at 240-276-3464. For more information regarding the reporting of adverse events, please go to http://www.fda.gov/cdrh/mdr/.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Barbara Buchele
for MXM
Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known): K052639
Device Name: Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer
The indications for use for the Generation 4® Polished Femoral Hip Prosthesis with Proximal Cement Spacer include:
- Non-inflammatory degenerative joint disease including osteoarthritis and 1. avascular necrosis.
-
- Rheumatoid Arthritis.
-
- Correction of functional deformity.
- Treatment of non-union, femoral neck fracture, and trochanteric fractures of 4. the proximal femur with head involvement, unmanageable using other techniques.
-
- Revision of previously failed total hip arthroplasty.
The Generation 4® Polished Femoral Hip Prosthesis with Proximal Coment Spacer is intended for cemented use only and may be used in partial and total hip arthroplasties.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use NO (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Claraa Buelund
(Division Sign-Off) Division of General, Restorative, and Neurological Devices
510(k) Number K052639